WEBULL
WebtradeDownload

OmniAb Leads The Pack Of 3 Intriguing Penny Stocks

Simply Wall St · 2d ago

In the last week, the market has stayed flat, but over the past 12 months, it has risen by 14%, with earnings expected to grow by 17% per annum in the coming years. For those looking to invest in smaller or newer companies, penny stocks — despite their vintage name — can still offer surprising value when backed by strong financials. This article explores several intriguing penny stocks that demonstrate financial strength and long-term potential.

Below we spotlight a couple of our favorites from our exclusive screener.

OmniAb (OABI)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: OmniAb, Inc. is a biotechnology company that licenses discovery research technology to pharmaceutical and biotech companies, as well as academic institutions, for therapeutic discovery across the United States, Europe, Japan, China, and Canada with a market cap of approximately $693.51 million.

Operations: The company's revenue is primarily generated from its Medical Labs & Research segment, amounting to $38.46 million.

Market Cap: $693.51M

OmniAb, Inc. presents an intriguing case in the penny stock arena, with its biotechnology focus and recent strategic collaborations enhancing its growth prospects. The company reported a significant revenue increase to US$27.84 million for the first half of 2026, alongside a reduced net loss compared to the previous year. Despite being unprofitable and experiencing high share price volatility, OmniAb's debt-free status and strong cash position provide some financial stability. Recent partnerships with Eli Lilly and VERAXA Biotech reflect potential future revenue streams through milestone payments and royalties, highlighting promising avenues for expansion in therapeutic discovery.

OABI Revenue & Expenses Breakdown as at Oct 2026
OABI Revenue & Expenses Breakdown as at Oct 2026

Taboola.com (TBLA)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Taboola.com Ltd. operates an artificial intelligence-based algorithmic engine platform across multiple countries, including Israel, the United States, and the United Kingdom, with a market cap of approximately $918.53 million.

Operations: The company generates revenue primarily through its advertising segment, which totaled $1.96 billion.

Market Cap: $918.53M

Taboola.com Ltd. showcases both potential and challenges within the penny stock domain. The company's recent launch of Realize ID aims to enhance advertiser conversion efficiency, leveraging its AI-driven platform. However, legal issues loom with a class action lawsuit alleging misleading statements impacting investor confidence. Despite missing revenue guidance in Q2 2026, Taboola's financial health remains stable with more cash than debt and short-term assets covering liabilities. While earnings have surged by a very large margin over the past year, driven partly by one-off gains, the stock trades significantly below estimated fair value amidst ongoing volatility concerns.

TBLA Revenue & Expenses Breakdown as at Oct 2026
TBLA Revenue & Expenses Breakdown as at Oct 2026

SES AI (SES)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: SES AI Corporation focuses on developing and producing AI-enhanced lithium metal and lithium-ion rechargeable battery technologies for various applications, including electric vehicles and drones, with a market cap of approximately $297 million.

Operations: The company's revenue is derived entirely from its Batteries / Battery Systems segment, totaling $23.46 million.

Market Cap: $296.99M

SES AI Corporation, a penny stock in the U.S., is navigating both growth opportunities and challenges. The company recently expanded its Chungju manufacturing facility to meet rising demand for high-performance batteries, enhancing its production capacity significantly. Despite forecasting revenue between US$30 million and US$35 million for 2026, SES AI remains unprofitable with a net loss of US$30 million in the first half of the year. It faces potential delisting from NYSE due to low share prices but maintains financial stability with short-term assets exceeding liabilities and no meaningful shareholder dilution over the past year.

SES Revenue & Expenses Breakdown as at Oct 2026
SES Revenue & Expenses Breakdown as at Oct 2026

Make It Happen

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.